A groundbreaking study: The Alma Hybrid™ in action
A recent publication, “Keloid and Hypertrophic Scars Treatment”, published in Plastic Surgery (2024)2, sheds light on the effectiveness of the Alma Hybrid. The study evaluated the Hybrid Proscan applicator on 61 patients with both keloid and hypertrophic scars.
The results were impressive. Hypertrophic and keloid scar patients experienced significant reductions in their Vancouver Scar Scale (VSS) scores (62% ± 8% and 58% ± 7, respectively). This indicates a marked improvement in scar appearance2. Additionally, the study reported high patient satisfaction and minimal side effects2.
These findings position Alma Hybrid™ as a first line of treatment for scarring and a valuable addition specialists armamentarium.
Unveiling the power of three: The Alma Hybrid™ Technological Advantage
The Alma Hybrid™ stands out for its unique ability to combine three highly powerful, distinct yet complementary energy sources:
- CO2 laser: This ablative laser precisely removes surface irregularities while stimulating collagen production for improved texture.
- Erbium-Glass laser: This non-ablative 1540nm laser works deep within the skin, promoting collagen synthesis without damaging the surface.
- Ultrasound technology: This innovative feature facilitates deeper penetration of the laser energy, allowing for more targeted and customised treatment.
This customisable synergy is what truly sets the Alma Hybrid™ apart. Alma’s patented HyGrid™ technology weaves these lasers into the ideal pattern. In the case of serious scarring, the two lasers can be stacked on top of each other, allowing the CO2 to reach much more profound depths for seriously transformative results. The HyGrid™ versatility allows practitioners to also adjust ablative-to-non-ablative ratios to:
- Treat a range of the most complex scars (Keloid, Hypertrophic and Keloid) by precisely treating multiple skin layers with an ablative, thermal and coagulative effect at once.
- Effectively balance results with recovery time for ultimate patient satisfaction.
- Treat all skin tones, up to Fitzpatrick 6, with the correct preparation and aftercare.
This level of precision and control is unmatched in any other CO2 device, redefining both scar revision and advanced rejuvenation.
While clinical studies exemplify the Alma Hybrid’s ability to deliver positive clinical outcomes, Alma is partnering with select advanced practitioners in the UK to deliver incredible patient outcomes:
Khatra Patterson, Nurse and Founder of KP Aesthetics: “For many patients, prominent facial scars can be emotionally devastating. The Alma Hybrid allows me to finally offer them real hope for improvement.”
Dr Munir Somji, Founder and Clinical Director of Dr Medispa: “This technology is unlike anything else. The combination of CO2, Erbium-Glass, and ultrasound provides exceptional versatility for achieving the best possible outcomes, even for the most advanced scar types.”
